Jinhe Biotechnology CO., LTD. (SHE:002688)
China flag China · Delayed Price · Currency is CNY
6.86
-0.05 (-0.72%)
Jul 18, 2025, 12:44 PM CST

Jinhe Biotechnology CO., LTD. Company Description

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera.

It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD.

was founded in 1990 and is based in Dalian, China.

Jinhe Biotechnology CO., LTD.
CountryChina
Founded1990
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees2,476
CEOChangxian Xie

Contact Details

Address:
1-7-2 Building 27
Dalian, Liaoning Province 116023
China
Websitejinhe.com.cn

Stock Details

Ticker Symbol002688
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100001HK7
SIC Code2834

Key Executives

NamePosition
Changxian XieGM and Director
You Shan NiuFinancial Director
Zhi Jun WangDeputy GM and Director
Yueqing WangDeputy GM and Non-Independent Director
Manman LuBoard Secretary and Director
Zhi Sheng WangDeputy General Manager
Ying Chun LiuDeputy General Manager
Yingzhen GuanDeputy General Manager
Lihang ZhouChief Accounting Officer
Mingsheng JianDeputy General Manager